DFISX | PIVYX | DFISX / PIVYX | |
Total Expense Ratio | 0.39 | 1.05 | 37% |
Annual Report Gross Expense Ratio | 0.39 | 1.34 | 29% |
Fund Existence | 29 years | 26 years | - |
Gain YTD | 27.051 | 23.324 | 116% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.9B | 340M | 4,088% |
Annual Yield % from dividends | 3.11 | 3.34 | 93% |
Returns for 1 year | 21.74 | 15.65 | 139% |
Returns for 3 years | 58.90 | 62.91 | 94% |
Returns for 5 years | 55.38 | 39.53 | 140% |
Returns for 10 years | 61.46 | 60.59 | 101% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RICFX | 65.84 | 0.07 | +0.11% |
American Funds Invmt Co of Amer R5 | |||
LICVX | 17.87 | N/A | N/A |
Lord Abbett International Equity R6 | |||
MSAWX | 21.41 | N/A | N/A |
Morgan Stanley Inst Asia Opp C | |||
JNGLX | 69.94 | N/A | N/A |
Janus Henderson Global Life Sciences D | |||
CVMAX | 20.33 | N/A | N/A |
Calvert Emerging Markets Equity A |